Guest guest Posted March 21, 2006 Report Share Posted March 21, 2006 From : Duclayan gduclayan@...> I just wanted to report on Dr. Borody's presentation last night. This e-mail is likely to be somewhat long and rambling. Sorry! First, there were nearly 600 people there, and they said that they were expecting 50! They also said that people had traveled from as far as Canada and Wisconsin to see the presentation. The place was packed. Dr. Borody started the talk by saying that he has a financial stake in a company called Giaconda, Ltd. which is planning to market the antibiotic treatment that he has tested. He didn't say this, but the Giaconda website ( http://www.giacondalimited.com/) calls the treatment " Myoconda. " (I Googled it.) It's good to know that Borody has a potential conflict of interest and that he is open and honest about it. I don't think this detracts from his research. Dr. Borody stated that since this treatment is still investigational, he uses it only to treat patients who are severely ill and who have failed most other treatments. As examples, he said that one patient had been told that she would need to have her colon removed. Another woman mentioned her daughter who was in the hospital with fistulas draining to her abdomen. Dr. Borody said that the treatment would be appropriate for her. One person said he was in remission and asked whether the treatment would be good for him. Borody responded, " If it ain't broke, don't fix it. " So, if you are doing well on the SCD and whatever other treatments you are using, I suspect that the triple-antibiotic therapy is not for you, at least not until further tests have been conducted and it becomes a more mainstream treatment. By the way, Dr. Borody did state that clinical trials of the triple antibiotic treatment are planned in North America for late 2006. He said November or December 2006. To find out more about this, I would suggest contacting Borody's clinic, the Center for Digestive Diseases in Australia: http://cdd.com.au/. You might also contact Giaconda, Ltd. at the website I gave above or see this page of their website: http://www.giacondalimited.com/pages/products/myo_conda.html. The Giaconda website states " Nevertheless, with the first Myoconda Phase III study complete, Giaconda has developed a clearly defined path to market for the product, with commercial launch in the US expected in 2008. " That probably means it won't be approved until 2010 at the earliest! Likely many of you already know about the proposed link between MAP and Crohn's, so I don't want to bore you with too many background details; also I'll not get into the controversy of whether this theory is correct or not. Suffice it to say that Crohn's closely resembles a bovine disease called e's Disease (pronounced yo-neez). e's Disease is a chronic diarrhea-causing infection caused by Mycobacterium avium paratuberculosis (MAP). Mycobacterial infections as a whole are difficult to treat with conventional antibiotics; leprosy and tuberculosis are other infections caused by mycobacteria. They generally require multiple antibiotics over an extended period of time. Dr. Borody stated that with the advent of AIDS, a number of patients developed Mycobacterium avium complex (MAC) infections. Drugs were developed to treat these infections; these drugs can also be used to treat MAP. Only two of the drugs that Dr. Borody uses in his regimen are available in the United States (I'm not sure which drugs he actually uses in his treatment. It might be on the CDD website), but he said that other available drugs could be substituted. To treat MAP it is very important to ALWAYS use at least three anti-MAP antibiotics. Using fewer than 3 anti-MAP antibiotics could potentially result in antibiotic resistance. Anti-MAP antibiotics include macrolides (Clarithromycin and Azithromycin), rifabutin, clofazimin, Ciprofloxacin (Cipro), levofloxacin (Levaquin), and Metronidazole (Flagyl). As many of you will no doubt note, some of these drugs are already used to treat Crohn's, though perhaps not in combination. As a side note, he specifically said that he didn't think that Xifaxan would have any effect against MAP. People come into contact with MAP through dairy products (including milk), meat, and water (which might have run-offs from farms…MAP appears to survive chlorine treatment…it is 100 to 330 more resistant to chlorine treatment than E. coli, Borody said). Borody showed colonoscopic photos from his patients that were truly amazing. These were patients with very severe disease, fistulas, pseudopolyps, strictures, and on and on. The photos from after the treatment showed completely healed tissue, with distinctive longitudinal scarring. Borody said that this scarring suggests to him that the triple therapy heals the MAP infection through all the layers of the gut mucosa. The scarring starts out as a fairly prominent rope-like feature and then softens over time, eventually becoming just a white line. Moreover, he said that there is no sign of inflammation in these patients, including microscopically. He said that with other treatments, when a patient goes into remission you can still see inflammation microscopically. With these patients, there is no inflammation at all. A side note on fistulas. Borody said that once the disease is brought under control with the triple therapy, the fistulas can be treated. He said that often fistulas will grow a skin-like layer on the inside of the passage, which is what prevents them from healing completely. He said that once the disease is in remission, they delicately curette the inside of the fistula to remove this skin-like layer. The fistula then heals closed. As I mentioned, Borody said that a Phase 3 clinical trial of the triple treatment in more than 200 patients has been completed in Australia. He presented results of this at the British Society of Gastroenterology in March 2005. Dr. Borody concluded that the results of the trial demonstrate a statistically significant improvement in achieving remission when using the triple therapy compared with conventional therapy and once remission was achieved, no significant difference was demonstrated in maintaining remission between triple therapy and conventional therapy. In lay terms, nearly twice as many patients achieved remission within 16 weeks on the triple therapy (66%) as achieved remission on Remicade (39%). I believe I've gotten those figures right, but my notes could be wrong. I do know that the triple therapy was significantly better than Remicade at inducing remission. Borody said the treatment is better than any other treatment he's seen. Now that I've brought up remission, let's address this issue of " cure. " Dr. Borody did not use that term, and in fact he stated that patients may need to be on the treatment for years, if not for a lifetime. I think he said 3 years at full strength and thereafter at half strength. He told the story of one patient who had been in remission and off treatment for 4 ½ years. Some other patients who were treated at the same time as this guy had relapsed, so they brought this patient in to have a colonoscopic look. In his ileum they found some small ulcers, so they put him back on a ½ strength treatment and he's remained in remission. One person asked if such a treatment might mess with normal gut flora. Borody said yes it would and that he apologized to the innocent bugs. J He said that his main objective was to restore the quality of life for the people who have been devastated by Crohn's and that might mean messing a bit with gut flora. However, he said the treatment is generally well tolerated and certainly more tolerated than other Crohn's treatments, such as Remicade (which also tends to lose efficacy over time, he said). Borody showed a short film at the end of his presentation that showed 5 or 6 patients talking about their experience with the treatment. They were all extremely positive, naturally. One thing that intrigued me was that a number of them mentioned that the treatment slightly changed their skin color. One man said it gave him a " tan, " and another patient said it made her skin " pinkish. " All who mentioned this side effect said that is was a small price to pay for feeling completely well. Also, they all looked completely normal in the film. A number of people in the audience asked if there were doctors in the U.S. who would prescribe the triple-treatment. There are a few, but Borody did not give contact information. Based on my reading, I think that two of these doctors may be Dr. Chamberlin in El Paso, Texas, .Chamberlin@... or wchamberlin@... , and Dr. Saleh Naser of Orlando, FL, 1-, nasers@.... I have not contacted these doctors, this is purely my own speculation. But if you desire this treatment, these might be the doctors in the U.S. who you could contact. At the presentation they were handing out three papers for additional reading. I would be very happy to photocopy these and mail them to anyone who sends me their mailing address. I was able to find one of the more interesting papers that was handed out on-line. It is written by the above-mentioned Drs. Chamberlin and Naser. You can find it at: http://www.medscimonit.com/pub/vol_12/no_2/8181.pdf When asked about specific advice for eliminating or reducing exposure to MAP in everyday life, Borody said that one could boil milk and water, " grill " cheese (whatever that means), and cook beef well before eating it. There have been studies that have shown that live MAP is found in milk bought at grocery stores in the U.S. and U.K. In the U.K. the study also looked at shelf-stable " UHT " milk (AKA Parmalat), which is pasteurized at much higher temperatures than other milks, and found no live MAP. Samples were small, however, so this is not conclusive. (By the way, if I wanted to make yogurt with UHT milk, could I skip the step of boiling it?) There was no further discussion of diet, and no mention of SCD (except between me and the people sitting near me as we chatted before the start of the presentation).One person did ask if Borody thought this might be a good treatment for ulcerative colitis. He said that the connection between MAP and Crohn's was made based on similarities between e's and Crohn's. e's and UC don't share these same similarities. That said, if he was presented with a severely ill UC patient who was facing having his/her colon removed, for example, he might consider trying the treatment. If the clinical trial in the U.S. is as successful at inducing remission as it was in the Australian trial, then this will truly induce a sea change in Crohn's treatment, and in ideas about the cause of Crohn's. Please let me know if you have any questions about the presentation or if you'd like copies of the handouts. All the best, ________________________________________ Loving Care,Grammy Gay IBS-1930, IBD-1984, SURGERY-1988, CD-1994, SCD-1997, REMISSION-1998, NO-MEDS. Put my address in your contact list or your address book. Grammy_Bauer@... for list serve *My Web Site: http://www.SCDiet.net/ hebegb70@... Support Group *Put in Subject: SCDiet SCD Pals or help, Please *** Or I may not see your post to me. ALSO: *** *FOR SCD-Friendly Doctor, Componding Pharmacy, and Vacation area, please ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ *LIST OF SCD FOODS: E-mail to scdiet@... SCDiet.com will provide this at no charge. In the subject put CARD REQUEST Give your name and address to get it snail mail. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Active Parenting Today Online Groups [parenting classes from the comfort of home] Join: *http://www.activeparenting.com/aptog.htm THERE IS A LIFE AFTER IBD! --------------------------------- Yahoo! Mail Bring photos to life! New PhotoMail makes sharing a breeze. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.